IP Verse

Modulation Of Apolipoprotein Ciii (Apociii) Expression

PatentPatent Analysis

EP2701713

IONIS PHARMACEUTICALS
Application Number
EP12776385A
Filing Date
Apr 27, 2012
Status
Revoked
Jul 19, 2019
Grant Date
Feb 7, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3770258B1
EP3400947B1
EP2906696B2

Bibliography

The patent EP2701713B1 was granted to Ionis Pharmaceuticals on Feb 7, 2018 following the initial filing on Apr 27, 2012 under the application number EP12776385A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

PFIZERNov 7, 2018ADMISSIBLE
STRAWMANNov 7, 2018ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents